𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity

✍ Scribed by Salem, Kelley; Brown, Charles O.; Schibler, Jeanine; Goel, Apollina


Book ID
123485079
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
737 KB
Volume
41
Category
Article
ISSN
0301-472X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


The increased expression of receptor act
✍ Mireya Fernández; Ana M Pino; Paula Figueroa; Juan P Rodríguez 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

## Abstract The receptor activator of nuclear factor‐kappaB ligand (RANKL) and interleukin‐1beta are osteoclast activating factors which are abnormally expressed in bone marrow stromal cells and plasma cells of multiple myeloma patients. In this work we analyzed RANKL expression in human bone marro